myelofibrosis

Explore academic connections and research related to this keyword

219
Views
14
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Mutational profiling in myelofibrosis: implications for management.
Bose, Prithviraj;Verstovsek, Srdan;
2019 international journal of hematology DOI: 10.1007/s12185-019-0... 254 views
2
Myelofibrosis in 2019: moving beyond JAK2 inhibition.
Schieber, Michael;Crispino, John D;Stein, Brady;
2019 blood cancer journal DOI: 10.1038/s41408-019-0... 301 views
3
A journey through infectious risk associated with ruxolitinib.
Sant'Antonio, Emanuela;Bonifacio, Massimiliano;Breccia, Massimo;Rumi, Elisa;
2019 British journal of haematology DOI: 10.1111/bjh.16174 279 views
4
Management of advanced phase myeloproliferative neoplasms.
Marcellino, Bridget;Mascarenhas, John;
2019 clinical advances in hematology & oncology : h&o 284 views
5
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Sankar, Kamya;Stein, Brady L;Rampal, Raajit K;
2019 cancer treatment and research DOI: 10.1007/978-3-030-20... 281 views
6
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis.
Breccia, Massimo;Luciano, Luigiana;Pugliese, Novella;Rossi, Elena;Tiribelli, Mario;Scalzulli, Emilia...
2019 Annals of hematology DOI: 10.1007/s00277-019-0... 188 views
7
How I treat polycythemia vera.
Spivak, Jerry L;
2019 Blood DOI: 10.1182/blood.201883... 251 views

Related Journals

Blood
ISSN: 1528-0020 388 views
British journal of haematology
ISSN: 1365-2141 518 views
Annals of hematology
ISSN: 1432-0584 557 views
international journal of hematology
ISSN: 1865-3774 406 views
blood cancer journal
ISSN: 2044-5385 411 views
clinical advances in hematology & oncology : h&o
ISSN: 1543-0790 356 views
cancer treatment and research
ISSN: 0927-3042 328 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

epigenetic mutations jak–stat splicing infection Management polycythaemia vera ruxolitinib myeloproliferative neoplasms essential thrombocythemia jak2v617f macrovascular thrombosis microvascular thrombosis polycythemia vera efficacy hydroxyurea